Does Rallies show Form 4 insider transactions for MMED?

Yes. Rallies tracks MMED insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is MMED research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MMED. It does not provide personalized investment advice.

MMED (MiniMed Group, Inc. Common Stock) Stock Analysis - Insider Trades

MiniMed Group, Inc. Common Stock (MMED) is a publicly traded the market company. As of May 21, 2026, MMED trades at $11.63 with a market cap of $3.06B and a P/E ratio of 0.00. MMED moved +6.98% today. Year to date, MMED is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $10.65 to $20.48. Analyst consensus is strong buy with an average price target of $20.85. Rallies surfaces MMED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading MMED stock inside the company?

Recent MMED insider activity includes Torbert Hank bought 10, Torbert Hank bought 20, Kachidza Johnson M bought 50.00K, Baffour Nana bought 50.00K, and Asante-Kissi Frank bought 15.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

MMED Key Metrics

Key financial metrics for MMED
Metric	Value
Price	$11.63
Market Cap	$3.06B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.00%
52-Week High	$20.48
52-Week Low	$10.65
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Recent MMED Insider Trades

Torbert Hank bought 10 (~$3.8) on Apr 24, 2013.
Torbert Hank bought 20 (~$29) on Mar 20, 2012.
Kachidza Johnson M bought 50.00K (~$250.00K) on Feb 22, 2010.
Baffour Nana bought 50.00K (~$250.00K) on Feb 22, 2010.
Asante-Kissi Frank bought 15.00K (~$75.00K) on Feb 22, 2010.

Latest MMED News

MiniMed Secures Canadian License for Simplera Sync Sensor and Type 2 Indication — Apr 28, 2026
MiniMed Gains FDA Clearance for Half-Size Flex Pump with 300-Unit Reservoir — Mar 18, 2026
MiniMed Raises $538M in 28M Share IPO at $20, Medtronic Retains 90% — Mar 9, 2026
MiniMed launches Nasdaq Global Select IPO as second-largest Medtech offering — Mar 6, 2026

MMED Analyst Consensus

13 analysts cover MMED: 0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.85.

Common questions about MMED

Who is trading MMED stock inside the company?: Recent MMED insider activity includes Torbert Hank bought 10, Torbert Hank bought 20, Kachidza Johnson M bought 50.00K, Baffour Nana bought 50.00K, and Asante-Kissi Frank bought 15.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MMED?: Yes. Rallies tracks MMED insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MMED research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MMED. It does not provide personalized investment advice.